InvestSMART

Mesoblast Limited (ASX: MSB) - Announcements

Current share price for MSB : $2.260 0.06 (2.59%)+

ASX company news and announcements for Mesoblast Limited (MSB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Mesoblast Limited (MSB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Mesoblast Limited (MSB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Mesoblast Limited (MSB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$2,941 Appendix 3Y for Eric Rose 7 Mar 2025 10:02AM $2.190 $2.260 risen by 3.20%
$2,941 Mesoblast Added to S&P ASX200 Index 6 Mar 2025 9:09AM $2.400 $2.260 fallen by 5.83%
$2,941 ZSP: Arcadium Lithium PLC to be removed from the S&P/ASX 200 28 Feb 2025 5:03PM $2.520 $2.260 fallen by 10.32%
$2,941 Ryoncil Pricing Set and Available This Quarter 27 Feb 2025 9:01AM $2.460 $2.260 fallen by 8.13%
$2,941 Corporate Presentation and Half Year Financial Results 27 Feb 2025 8:40AM $2.460 $2.260 fallen by 8.13%
$2,941 Half Year Report and Accounts (including Appendix 4D) 27 Feb 2025 8:37AM $2.460 $2.260 fallen by 8.13%
$2,941 Mesoblast 2025 Half Year Financial Results Webcast 26 Feb 2025 9:51AM $2.520 $2.260 fallen by 10.32%
$2,941 Initial Director's Interest Notice 24 Feb 2025 9:52AM $2.660 $2.260 fallen by 15.04%
$2,941 Director Appointment 24 Feb 2025 9:47AM $2.660 $2.260 fallen by 15.04%
$2,941 Ryoncil Highlighted at Tandem Transplantation Meetings 14 Feb 2025 9:50AM $2.900 $2.260 fallen by 22.07%
$2,941 Change in substantial holding 7 Feb 2025 10:26AM $2.990 $2.260 fallen by 24.41%
$2,941 Ryoncil Commercial Launch Update and Product Pipeline 31 Jan 2025 9:40AM $3.060 $2.260 fallen by 26.14%
$2,941 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jan 2025 9:32AM $3.060 $2.260 fallen by 26.14%
$2,941 Cleansing Notice 24 Jan 2025 5:02PM $2.870 $2.260 fallen by 21.25%
$2,941 Application for quotation of securities - MSB 24 Jan 2025 4:49PM $2.870 $2.260 fallen by 21.25%
$2,941 Cleansing Notice 22 Jan 2025 4:25PM $2.750 $2.260 fallen by 17.82%
$2,941 Application for quotation of securities - MSB 22 Jan 2025 4:22PM $2.750 $2.260 fallen by 17.82%
$2,941 Ceasing to be a substantial holder 22 Jan 2025 8:23AM $2.870 $2.260 fallen by 21.25%
$2,941 Appendix 3Y for Eric Rose 21 Jan 2025 9:59AM $2.780 $2.260 fallen by 18.71%
$2,941 Cleansing Notice 20 Jan 2025 9:08AM $2.690 $2.260 fallen by 15.99%
$2,941 Application for quotation of securities - MSB 17 Jan 2025 5:32PM $2.690 $2.260 fallen by 15.99%
$2,941 Ceasing to be a substantial holder 16 Jan 2025 6:04PM $2.730 $2.260 fallen by 17.22%
$2,941 App 3Ys S Itescu J Bell W Burns P Facchina E Rose P Krause 16 Jan 2025 5:28PM $2.730 $2.260 fallen by 17.22%
$2,941 Notification regarding unquoted securities - MSB 16 Jan 2025 5:11PM $2.730 $2.260 fallen by 17.22%
$2,941 Notification of cessation of securities - MSB 15 Jan 2025 6:05PM $2.650 $2.260 fallen by 14.72%

201 - 225 of 1201 results

Page 9 of 49

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.